Theelen et al. demonstrated the absence of PD-L1 in tumoral cells in non-small-cell lung cancer (NSCLC); they suggested that impairment of IFN-γ signaling in tumor cells could be the cause of this phenomenon [69]. The gene discussed is IFNG; the disease is non-small cell lung carcinoma.